Danielle LaGrave, MS, LCGC, Genetic Counselor
Danielle LaGrave is a genetic counselor with ARUP's Maternal Serum Screening program and Cytogenetics Department. She is certified by the American Board of Genetic Counseling, is licensed by the state of Utah, and is a member of the National Society of Genetic Counselors and the American Society of Human Genetics. Ms. LaGrave received her MS in genetic counseling from California State University, Northridge, and has been a practicing genetic counselor since 1996.

Arthur Brothman, PhD, FABMG, FACMG
Medical Director, Cytogenetics Laboratory
Dr. Brothman is a medical director of the Cytogenetics Laboratory at ARUP and professor of pediatrics and adjunct professor of human genetics and pathology at the University of Utah School of Medicine. He received a PhD and MS in genetics from the University of Arizona and is certified by the American Board of Medical Genetics, with a subspecialty in clinical cytogenetics.

Dr. Brothman served on the College of American Pathologists/American College of Medical Genetics Cytogenetics Resource Committee where he was charged with establishing a proficiency test for CGH microarrays. He has been active in the Southwest Oncology Group, the Children’s Oncology Group, and multiple peer-review committees through the National Institutes of Health and the American Cancer Society. Dr. Brothman was elected to the board of directors for the American Cytogenetics Conference and, among other national appointments, is a founding fellow of the American College of Medical Genetics.

Katherine Geiersbach, MD, FCAP
Medical Director, Cytogenetics, Molecular Cytogenetics, and Molecular Oncology Laboratories
Dr. Geiersbach is a medical director of the Cytogenetics, Molecular Cytogenetics, and Molecular Oncology laboratories at ARUP and an assistant professor of pathology at the University of Utah School of Medicine. Dr. Geiersbach received her MD from the University of Colorado School of Medicine and completed her residency in pathology at the University of Colorado Health Sciences Center. She is certified by the American Board of Pathology in anatomic and clinical pathology, with subspecialty certification in molecular genetic pathology and clinical cytogenetics. She is a fellow of the College of American Pathologists and the American College of Medical Genetics. Her research interests include DNA-based genotyping of molar pregnancy, cytogenetic abnormalities in spontaneous pregnancy loss, and genetic abnormalities in cancer.

Shashirekha Shetty, PhD, FCCMG, FACMG
Medical Director, Cytogenetics
Dr. Shetty is the medical director of the Cytogenetics Laboratory at ARUP and an assistant professor in the Department of Pathology at the University of Utah School of Medicine. She received her PhD from the University of Mumbai in India and completed a cytogenetics fellowship at the University of Calgary in Calgary, Canada. She is a fellow of the Canadian College of Medical Geneticists as well as the American College of Medical Geneticists and the American Board of Medical Genetics. Most recently, Dr. Shetty?s research focused on the investigation of the use of mitogens to identify new cytogenetic prognostic markers in chronic lymphocytic leukemia (CLL); she is also interested in understanding the genetics of well-differentiated liposarcomas.

Sarah South, PhD
Medical Director, Cytogenetics, Molecular Cytogenetics, and Genetic Processing,
Dr. South is a medical director for the Cytogenetics, Molecular Cytogenetics, and Genetic Processing laboratories at ARUP and an assistant professor of pediatrics and adjunct professor of pathology at the University of Utah School of Medicine. Dr. South received her PhD from the John Hopkins School of Medicine in human genetics, and completed a postdoctoral research fellowship in prenatal genetics at the John Hopkins Hospital and a clinical cytogenetics fellowship at the University of Utah School of Medicine. She is the also the director of the ABMG-certified training program in clinical cytogenetics at the University of Utah. Dr. South regularly lectures for the genetic counseling and nursing programs and coordinates chromosome rounds for the Division of Medical Genetics at the University of Utah. Her research interests include the development of new technologies for enhanced detection and characterization of chromosome abnormalities.

Jia Xu, MD
Medical Director, Cytogenetics Laboratory
Dr. Xu is a medical director for the Cytogenetics Laboratory at ARUP and an assistant professor in the Department of Pediatrics at the University of Utah. Dr. Xu received his MD degree at the Hunan Medical College in Changsha, China. He completed his cytogenetics training at the University of Rochester School of Medicine and holds a clinical cytogenetics certificate from the American Board of Medical Genetics. His recent research involved a project on the diagnosis of pediatric sarcomas using FISH probes; he has been involved in preparing a manuscript comparing FISH and PT-PCR for Ewing sarcoma samples. Dr. Xu is a member of the American Society of Human Genetics and has a board certification with the American Board of Medical Genetics.